Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Angiodynamics Inc (NQ: ANGO )

6.725 -0.025 (-0.37%)
Streaming Delayed Price Updated: 11:54 AM EST, Nov 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Angiodynamics Inc

< Previous 1 2 Next >
AngioDynamics to Present at the Needham Virtual Growth Conference
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics to Report Fiscal 2022 Second Quarter Financial Results on January 6, 2022
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics Reports Fiscal 2022 First Quarter Financial Results; Updates Guidance
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics to Report Fiscal 2022 First Quarter Financial Results on September 30, 2021
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics to Present at the Canaccord Genuity Virtual Growth Conference
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics Reports Fiscal 2021 Fourth Quarter and Full-Year Financial Results
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics Announces Details for Investor & Technology Day on July 13, 2021
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics to Report Fiscal 2021 Fourth Quarter and Full-Year Financial Results and Host Investor & Technology Day on July 13, 2021
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics Receives 510(k) Clearance for AlphaVac Mechanical Thrombectomy System
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics to Present at the UBS Virtual Global Healthcare Conference
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics Submits 510(k) Application to FDA for AlphaVac Mechanical Thrombectomy System
From AngioDynamics, Inc.
Via Business Wire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.